Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation ...
Mon, Nov 7th 2011
Medical News Today
Xarelto (rivaroxaban), an anti-clotting medication, has been approved by the FDA for patients with non-valvular atrial fibrillation to reduce stroke risk. Xarelto, a Factor Xa inhibitor, acts at a crucial point in the blood-clotting process and stops ...
Read more